Regulation and pharmacological targeting of RAD51 in cancer is a research paper published in NAR Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 87 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 ES024872
National Institutes of Health
Grant: R01 ES030335
National Institutes of Health
Grant: R01CA238315
National Institutes of Health
Grant: 5R01CA218026
American Cancer Society
Grant: 129182-RSG-16-043-01-DMC
Stand Up To Cancer
Grant: SU2C-AACR-IRG-02-16
NCI NIH HHS
Grant: R01 CA218026
National Institutes of Health
Grant: 5R01CA218026-03
The Function of EGFL6 in Ovarian Cancer Cell Biology, Tumor Initiation, and Therapy
National Institutes of Health
Grant: 5R01CA238315-02
ALDH Inhibition as Modulator of Tumor Immunobiology
National Institutes of Health
Grant: 5R01ES024872-03
Replication fork dynamics and repair by Rad51 paralogues after DNA alkylation
National Institutes of Health
Grant: 7R01ES030335-05
Replication fork dynamics and repair by Rad51 paralogues after DNA alkylation
FWCI
3.65
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals